Introduction: Regular physical exercise appears to potentiate the effects of pharmacological treatment for arterial hypertension. As such, regular exercise is recommended as an adjuvant treatment in hypertensive subjects by both European and American guidelines. Crucially, however, there are no precise recommendations on the type of physical exercise and how it should be instituted. Aerobic Interval Training (AIT) is a new and novel type training that appears to be beneficial to patients suffering from various medical conditions. There is a distinct lack of evidence on how it affects arterial hypertension. The aim of this study was to evaluate the influence of a 5 month period of regular AIT on blood pressure, carotid femoral pulse wave velocity (PWV) and applanation tonometry indexes in patients previously treated pharmacologically for mild or moderate arterial hypertension.
Introduction
Arterial hypertension is the leading cause of death according to statistics published by the World Health Organization (WHO) and the International Bank of Reconstruction and Development in their official
The meaning of non-pharmacological intervention in arterial
Current guidelines pertaining to the management and treatment of patients with arterial hypertension (ESH/ESC 2007 and 2013) outline our current state of knowledge about the non-pharmacological treatment of this illness [8, 9] . Our current understanding of reducing modifiable risk factors includes stopping the use of tobacco products, reduction and stabilization of body mass, minimizing the intake of excess alcohol, regular physical activity, reducing the intake of salt, increasing the intake of fruit and vegetables, and partaking in a low fat diet which seeks to reduce the intake of saturated fats. Physicians should strive to implement all of these recommendations in all patients suffering from arterial hypertension already receiving pharmacological treatment as well as those patients with essential hypertension. The goal of these non-pharmacological modifications in lifestyle is to decrease blood pressure, reducing the impact of modifiable risk factors and subclinical end organ damage, as well decreasing the global risk of cardiovascular events.
Subclinical organ damage
Guidelines of the European Society of Hypertension from 2013 [8] , list organ damage secondary to hypertension and their estimated global risk (Table 1) .
Left ventricular hypertrophy
Carotid artery thickening (IMT>1.5 mm) or the presence of cholesterol plaque or focal increase of IMT of 50% or more or more than 0.5mm Pulse wave velocity measured between carotid artery and femoral arteries>10 m/s Ankle-brachial index<0.9
Increased serum creatinine levels (M: 115-133 mmol/l)(1.3-1.5 mg/dl), K: 107-124 mmol/l (1.2-1.4 mg/dl), low estimated glomerular filtration rate calculated using the MDRD formula ((<60 ml/min/1.73 m²) or creatinine clearance calculated using the Cockrofta-Gaulta formula (<60 ml/min)) Microalbuminuria of 30-300 mg/24h or albumin creatinine ratio ≥ 22 (M); or ≥ 31 (K) mg/g creatinine Retinopathy stage III or IV (Keith-Wgener classification)
Micro bleeding/ischeamic stokes of brain ESH/ESC guidelines published in 2013 were modified to include a pulse pressure of ≥60 mmHg as contributing to organ damage, along with a modified PWV value which now has a cut off value of >10 m/s. The change in PWV value stems not from epidemiological data but rather due to efforts to correctly quantify the length of the aorta using imaging studies. In practice, this means that one must multiply the measured PWV value by a co-efficient of 0.8. In order to facilitate comparison with available published data, we decided to list the actual measured change in PWV without the use of the co-efficient as outlined in the current guidelines.
The role of artery stiffness and subclinical organ damage ESH and ESC guidelines from 2007 were the first to note arterial stiffness, measured using carotid-femoral Pulse Wave Velocity, as a marker of vessel damage and that it should be considered when determining cardiovascular risk in patients with hypertension [9] . The use of PWV as a measure of arterial stiffness was further highlighted in ESH/ESC guidelines published in 2013 along with a new cut off value [8] . This value has previously been recognized as the gold standard for measuring regional arterial stiffness by the Expert Committee of the European Society of Cardiology [10] .
The importance of physical exercise in patients suffering from hypertension
The ESH/ESC recommendations published in 2007 and 2013 paid particular attention to physical exercise and its role as one the modifiable risk factors for cardiovascular disease along with its effects on the average blood pressure of patients with hypertension [8, 9] . This form of non-pharmacological intervention was particularly highlighted since its introduction is relatively easy; it is associated with a significant reduction in cardiovascular risk regardless of baseline blood pressure or the influence of other risk factors [11] . Studies have demonstrated that endurance focused aerobic training decreases resting systolic and diastolic blood pressure by an average of 3.0 and 2.4 mmHg respectively, and by 3.3 and 3.5mmHg in daytime ambulatory measurements. It was also observed that regular physical exercise decreased resting systolic and resting diastolic blood pressure in patients with hypertension by 6.9 and 4.9 mmHg respectively, which was a greater decrease than in patients who were not known to have hypertension and experienced a decrease of 1.9 and 1.6 mmHg respectively [12] . Physical exercise was linked with a reduction in body mass [13] , a decrease in the amount of fat tissue [14] , a decrease in waist size [15] , improved insulin sensitivity and an increase in HDL levels in patients with ischemic heart disease [16] .
The effects of exercise on arterial stiffness
Numerous studies have demonstrated that regular physical activity reduces arterial stiffness. The mechanism by which this happens is not yet fully understood, although it has been observed that this is likely due to multifactorial aetiologies including vessel remodelling, improving endothelial functioning, as well as metabolic and enzymatic changes in vessel walls. Research carried out by Madhura et al. involved a group of students undergoing an 8 week training regime composed of aerobic training undertaken on a treadmill (3 sessions per week, with each session lasting 1 hour at a constant load and with cardiac monitoring). Measurements pertaining to arterial stiffness, including values of gain and carotid-femoral pulse wave velocity, were significantly decreased in this group. 4 weeks later, PWV and AIx (augmentation index, AIx) had returned to baseline values in the group of students who had undertaken the training regime but had since stopped training [17] . Gando et al. found that in a population of subjects aged 34 to 63, arterial stiffness was not affected by obesity, and however, the duration of the effects of exercise on the reduction of arterial stiffness depended on the time since training [18] . Cited studies and their results show a correlation between changes in arterial stiffness and exercise, the intensity of exercise, and its duration. Guided by these studies, we developed our training program for our subject.
Materials and Methods

Study group-inclusion and exclusion criteria
Our study group was composed of 60 patients with 1st and 2nd degree hypertension as defined by ESH and ESC classification from 2013 [8, 9] . The study group included subjects aged between 35 and 70 who were receiving monotherapy or who were treated with two antihypertensives (excluding for beta-blockers). Subjects received the same pharmacological treatment for at least two years and were regularly found to have a blood pressure below 140/90 mmHg during clinic appointments. We limited the type of antihypertensives used to treat our subjects to five basic groups of antihypertensives along with their doses: calcium channel blockers were limited to amlodipine at a dose of 5 or 10 mg per day, ACE inhibitors were limited to quinapril at a dose of between 20 and 40 mg per day, diuretics were limited to hydrochlorothiazide at a dose of between 12.5 to 25 mg per day, and sartans were limited to losartan at a dose of between 100 and 200 mg per day. Patients were randomly selected into two groups by pairs taking into account their age, sex, and ongoing antihypertensive treatment. One group was then selected to undergo the 5 month long training plan. The two resultant groups did not significantly differ in regards to age, sex and ongoing antihypertensive treatment. During the exit visit, subjects underwent anthropometric measurements, office blood pressure measurements, and indicators of arterial stiffness and applanation tonometry. Exclusion criteria are listed in Table 2 .
Secondary hypertension
Chronic kidney or liver failure 
Instrumented measurement of arterial stiffness
Instrumented measurement of arterial stiffness was carried out according to criteria outlined by ESC expert consensus regarding arterial stiffness [19] (Table 3) . PWV (carotid-femoral pulse wave velocity) measurement using the Complior® device PWV measurements were taken following the criteria outlined above and using the Complior® device (Colson, Garges les Genosse, France. Software version 2.1), as described by Asmara et al. [20] .
PWV (carotid-femoral pulse wave velocity) measured using the SphygmoCor® device
The SphygmoCor® device (AtCor Medical, Sydney, Australia, model MM3, software version 7.01 S) allows for obtaining several parameters of pertaining to arterial stiffness. In our study we used the device to measure the following:
2. Central index of pulse wave augmentation (AIx-calculated using applanation tonometry and the obtained tracing of the pulse wave at the radius, brachial blood pressure measurement and estimation of central pressures (i.e. in the central aorta)).
3. Central pressure: systolic, diastolic and pulse pressure (calculated based on radial blood pressure and analysis of the pulse wave measured at the radial artery using the transfer function [21, 22] ). The most important element of the study was to identify in the tracing of the central pulse wave pressure the point of wave reflection. The SphygmoCor® device has a built in a highly sensitive tonometry sensor used for pulse wave measurement. The PWV measurement is actually a two-step process. Firstly, the pulse wave is measured at the carotid artery with concurrent ECG recording, whilst the femoral artery pulse wave is recorded next along with concurrent ECG. The ECG tracings are important as they are used to synchronize the two pulse wave pressure measurements in order to calculate the delay (T) of the pulse pressure between the two areas [23] .
The evaluation of normal daily activity (Baecke scale)
Daily living activity was assessed using personalized The Questionnaire of Baecke for Measurement of a Person's Habitual Physical Activity [24] .
Intervention-aerobic interval training
Our study group undertook a 5 month long training program designed using the most current published evidence. This was undertaken on top of the current recommendations pertaining to physical activity in patients with hypertension which the control group was to restricted [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . The physical training undertaken by our study group was composed of 40 sessions with 2 sessions per week. The sessions were supervised by a doctor and physiotherapist. The 50 minute program was based on the most up to date published evidence and was composed of resistance training which included a 10 minute warm up period (jogging and gymnastics), 30 minutes of interval aerobic exercises on the cycle ergonometer, followed by a 10 minute session of stretching. The goal of every training session was for the subject undertaking the training session to reach 80% of their maximum heart rate without letting their heart rate to drop beneath 60% of their maximum heart rate during recovery periods ( Figure 1 ). Peak (176 bpm)-maximum achieved heart rate Average (134 bpm)-average heart rate, Energy consumption-energy expenditure during training session, Training effect-a measure of intensity of effort based on the devices 5 point scale, Duration-duration in minutes of the training session (min).
Results
Baseline characteristics of the study and control groups
The baseline characteristics of the study and control groups are presented in Tables 4 and 5 The groups were not significantly different in regards to relevant anthropometric values, their blood pressure and pulse measurements, the length of time they were known to be hypertensive. Basic biochemical tests were also obtained from the two groups. The biochemical tests included a full blood count, renal function tests, as well as lipid profile testing (excluding serum triglyceride levels). 
Effects of the training intervention
Values of office blood pressure (systolic and diastolic) along with carotid-femoral PWV and values pertaining to applanation tonometry after 5 months of intervention are shown in Tables 6 and 7 .
The study group appears to have experienced a significant decrease in both systolic and diastolic blood pressure after completing the 5 month training program (p3) ( Table 6 ). In regards to indexes of arterial stiffness determined using both the Complior® and SphygmoCor® devices, we found a significant decrease in carotid-femoral pulse wave velocity measured using the Complior® device in the study group. which experienced an a decrease in velocity from an initial value 10.30 m/s (± 1.18 m/s) to that of 9.26 m/s (± 1.11 m/s), (p3=0.0001, Table 7 ). In the control group, which did not undergo the 5 month training program, no change in PWV was observed using the Complior® device (p4=0.7645, Table 7 ). Whilst the two groups did not differ significantly in regards to this parameter during the initial visit (p1=0.9291, Table 7 ), during the second visit there was a significant decrease in PWV in the study group when compared to the control group (p2=0.0418) ( Table 7) . There were no significant differences between the two groups in regards to carotidfemoral pulse wave velocity measured using the SphygmoCor® device during the first visit (p1=0.2170) ( Table 7) . However during the second visit we found a significant difference in PWV during the second visit between both groups (p3=0.0001) ( Table 7) . This was a result of a significant decrease in PWV SphygmoCor® in the study group between visit 1 and visit (8.37 ± 1.03 m/s vs. 7.48 ± 0.97 m/s, p3=0.0001) ( Table  7) . The studied and control groups did not significantly differ in regards to indicators of applanation tonometry during the first visit. That is in regards to central systolic blood pressure (SBP centr) (p1=0.1449). Central diastolic blood pressure (DBP centr) (p1=0.2313). Pulse pressure (PP) (p1=0.3924). Central wave pressure augmentation index (AIx centr) (p1=0.0792) as well as peripheral wave pressure augmentation index (AIx per) (p1=0.5548) ( Table 7 ). The study group was found to have a decrease in central SBP between visit 1 and visit 2, that is after the 5 month training program. The SBP decreased from a value of 131.13 ± 13.47 mmHg to that of 124.7 ± 12.73 mmHg (p3=0.0058) ( Table 7) . Central diastolic blood pressure did not change in response to the training program (p3=0.2228) however central pulse pressure did significantly decrease from 44.26 ± 9.0 mmHg during the first visit to 40.26 ± 8.6 mmHg during visit 2 (p3=0.0358) ( Table 7) . We did not observe a change in the control group in regards to central systolic blood pressure (p4=0.8178), central diastolic pressure (p4=0.1049), as well as central pulse pressure (p4=0.8380) between visit 1 and visit 2. The difference the study group and the control group during visit 2 were not significant however, neither for central systolic blood pressure not for central (p2=0.9999) nor for central PP (p2=0.4825). During the second visit the control group was found to have a central diastolic pressure of 80.96 ± 10.75 mmHg which was actually lower than that of the study group 84.43 ± 11.05 mmHg and on the border of statistical significance (p2=0.0475) Table 7 ). A significant difference was also found between the central wave pulse augmentation indexes (p3=0.0397) ( Table 7) and peripheral wave pulse augmentation indexes (p3=0.0004) in the study group (Table 8) 
Regression analysis
In order to define the factors leading to the observed reduction in arterial stiffness, we carried out multiple regression analysis in which we determined the effect on the arterial stiffness index (carotidfemoral PWV) other changes observed in the study group such as office SBP, office DBP, BMI, Serum ADMA concentration, microalbuminuria, hs-CRP and applanation tonometry indices. At a level of R ² =22% for the entire model, only a change in DBP (R=0.19, p=0.0043) and change in SBP (R=0.18. p=0.009) significantly contributed to a change in arterial stiffness determined using PWV Complior® (ΔPWV). In the multiple regression analysis carried out, which was based on the same model, we could not find variables which would influence central pulse pressure (ΔPP).
Discussion
Carotid-femoral pulse wave velocity in hypertensive subjects measured using Complior® and SphygmoCor® devices after undergoing regular interval training
The average reduction of carotid-femoral PWV obtained in our study and measured using the Complior® device was found to be 1.04 m/s and 0.89 m/s for the SphygmoCor® device, which accounts for approximately a 10% change from the initial values in the study group. Taking into account the short time of intervention and the relatively mild training regime (2 training sessions per week), the obtained result appears quite significant. In the study performed by Guimaraes et al. [35] which included a shorter intervention (4 months of training) and was carried out on 65 patients with an average age of 41 ± 7 years (i.e. lower than in our study), a significant reduction of carotid-femoral PWV was also noted. In the aforementioned study, training sessions lasted 40 minutes and were composed of interval training at a frequency of 2 times per week. Subjects enrolled in the study undertook 6 to 7 training cycles on a treadmill during each session. The carotid-femoral PWV of the subjects studied (measured using Complior® device) decreased from 9.44 ± 0.91 m/s to 8.9 ± 0.96 m/s (p=0.009), a change of 6%. Much like in our study, interval training of a similar intensity resulted in a significant reduction in arterial stiffness. As part of the same study, subjects were also exposed to training sessions of the same intensity which was continues and not broken up into intervals. These subjects were found not to experience a significant decrease in PWV [35] . What is more interesting, however, is that the authors of the study did not find a significant decrease in average values of blood pressure obtained using 24 hour monitoring in either group partaking in the training sessions. A decrease in 24 hour ABPM was significant only in patients with high initial values of office blood pressures (above the median value). Therefore, the reduction in PWV was not and could not be linked with a decrease in arterial hypertension, which the main factor influencing the reduction in carotid-femoral PWV was found in our results. Kraft et al. also reported about the lack of correlation between the effects of exercise on hypertension [36] . Their study was based on 276 recruited subjects who were already performing exercise at a fitness club. 61 of their subjects were found to be suffering from hypertension and had an average age of 57 years. The study found no reduction in hypertension or carotid-femoral PWV in the patients with hypertension. Surprisingly, exercise was found to significantly reduce PWV by approximately 8% in the remaining subjects who were not noted to be hypertensive at baseline. This was not linked with a decrease in blood pressure, which is less surprising. Perhaps the key reason as to why the hypertensive subjects did not experience a reduction in PWV was because they were already enrolled in a training program. However, given the higher average age of subjects in our group and in all likelihood a relatively high percentage of subjects with isolated systolic hypertension (which the authors highlight themselves); the key factor may actually be the age of the subject. Madden et al. [37] research using 52 subjects with hypertension complicated by diabetes and hyperlipidemia and who were on average 69.3 ± 0.6 years of age. They found that subjects who underwent 6 months of regular aerobic exercise both on a treadmill and cycle ergometer (3 training sessions a week each lasting 60 minutes) experienced only a transient reduction in carotid-femoral PWV after 3 months of training, however at 6 months the effects were much weakened, with almost no significant difference between the group partaking in training and the group not partaking in training. The authors noted in their discussion that the training sessions could not reverse the permanent changes to the structure of artery walls and therefore PWV found in subjects with hypertension complicated by other risk factors such as type 2 diabetes. A reduction in PWV was noted in middle aged (approximately 53 year old) patients as a result of regular physical exercise who were not known to have hypertension [38] including middle aged patients with diabetes [39, 40] . Exercise was noted not to have an effect on PWV in older patients by authors other than Maiden et al. [41, 42] . Drawing on conclusions from our study and those previously cited, the optimal group of patients to undergo interval training for the purpose of reducing arterial stiffness is therefore composed of younger patients (ideally below 55 years of age). Epidemiological data shows that above 55 years of age, the likelihood of having isolated systolic hypertension increases. Exercise as an intervention for hypertension and with the goal of reducing PWV should be undertaken as data from literature points to a similar effect between physical training and a pharmacological approach. For example, Rajzer et al. [43] noted a decrease in PWV of 14% during a 6 month long period of ACEInhibitor monotherapy. During the PEACE study, a 52 month long observational study. the group being treated using Trandolapril was found to have a carotid-femoral PWV of 10.4 m/s. 7% lower than in the group not receiving the medication (11.2 m/s) [44] . Studies carried out by White et al. [45] which included 6 months of therapy with Eplerenone and amlodipine, showed a decrease in PWV of approximately 13%. Atenolol and Nebivolol were found to decrease carotid-femoral PWV by 11% during a 4 week long session of monotherapy [46] . Inevitably, most studies pertain to a reduction in PWV whilst patients undergo therapy with ACE inhibitors including not only trandolapril and quinapril but also perindopril [47] , ramipril [48] , enalapril [49] and cilazapril [50] . In all cases, the reduction in PWV during the time of therapy which lasted from a few months to 2 years was found to be in the order of several percent. We would like to highlight that our study, which involved 5 months of exercise. PWV was reduced by approximately 8% when compared to baseline measurement. Meta-analysis performed by Vlachopoulos et al. on 14 studies carried out between 1999 and 2010 found a strict correlation between carotid-femoral PWV and cardiovascular risk [51] . Carotidfemoral PWV was found to be the strongest predictor of cardiovascular events stronger than any single risk factor and even certain dedicated combinations of risk factors. If was found that an increase of carotidfemoral PWV by 1 m/s was linked with an increase in cardiovascular events by 14%, with cardiovascular mortality being increased by 15%.
The reduction in carotid-femoral PWV found in our study was approximately 1 m/s. both when measured using the Complior® device and the SphygmoCor® device. We cannot allow ourselves to simply conclude that we reduced the cardiovascular risk of our subjects to the same degree (14% and 15%) as that found in the meta analysis carried out by Vlachopoulosa et al. Nonetheless. a decrease in carotid-femoral PWV using interval training should improve the long term prognosis of patients. as long as it is a long term effect which will persist with long term follow up.
Indexes of applanation tonometry in patients with hypertension after undergoing regular interval training
We have attached much less importance to the results derived from applanation tonometry in comparison to changes we observed in carotid-femoral wave pulse velocity because the values derived from applanation tonometry are merely indirect indicators of arterial stiffness [52] . Nonetheless, our study noted a significant decrease in central systolic pressure (p=0.0058), central pulse pressure (p=0.0358) and central (p=0.0397) and peripheral (p=0.0004) pulse augmentation index in subjects who underwent our training program. The study most similar to ours in regards to methodology was one carried out by Millen et al. [53] . The study included 39 subjects with 1st or 2nd degree hypertension, essential hypertension and obesity (average BMI was 30.9 kg/m 2 ). The subjects underwent 6 weeks of interval training at an intensity of 75% VO2max. No significant change was observed in central pulse pressure or in central and peripheral pulse augmentation index. Interestingly, central systolic pressure was found to decrease, which the authors linked with a decrease in the average blood pressure measured at the brachial artery (average blood pressure measured at the brachial artery is used to calculate the central blood pressure using a function of the SphygmoCor device). Much like in our study, Millen et al. demonstrated a decrease in peripheral blood pressure measured at the brachial artery after 6 weeks of training [53] . The most probable cause as to why the aforementioned authors did not find a decrease in central pulse pressure as well as the central pulse augmentation index in this groups which we found in our study, was that our study included younger participants (on average 44.4 years of age) and a significantly smaller baseline central pulse pressure in the group studied by Millen et al. (on average 38 mmHg). The latter value defines the group studied by Millen et al. as being composed of individuals with a low or proper central pulse pressure and rather elastic arteries. Studies carried out by Rakobowchuk et al. [54] . found that subjects undergoing a 6-week long interval training program of medium and hard intensity were found not to have had a significant decrease in central pulse pressure (p=0.61) and pulse augmentation index. This discrepancy in results might be because of the length of the training program (6 weeks vs. 5 months) as well as a lower intensity of training. It should also be noted that the method to establish both values, i.e. central pulse pressure and pulse augmentation index, was different than the method used by in our study and that of Millen et al. Our method was based on tonometry of the carotid artery, and not of the radial artery using the SphygmoCor® device. In a study by Spina et al. [55] which studied the effects of interval training on 80 year old subjects who undertook training sessions on cycloergometers and treadmills lasting around 13 months and during which subjects achieved up to 90% VO2max, no significant change in central pulse pressure or central augmentation index (AIx) was noted. Much like in the study carried out by Rakobowchuk et al. the tonometry was carried out using a Miliar sensor situated at the radial artery. In the study carried out by Spina et al. interval training was found not to affect the parameters of central pressure nor peripheral measurements of blood pressure and echocardiographical parameters of left ventricular filling. Spina et al. concluded that the 80 year old subjects had a decreased level of arterial flexibility and unfavourable parameters of filling (low ventricular compliance) which limited the ability of the subjects not only in regards to carrying out the training program but also in experiencing any beneficial effects. It is important to note that the average central pulse pressure of the subjects described by Spina et al. was approximately 65 mmHg, whilst in our study was found to be 44mmHg. This difference in the baseline of the subject groups defines the group studied by Spina et al. as patients with stiff arteries and isolated systolic hypertension, which explains why the subjects in the study by Spina et al. did not experience any changes in their applanation tonometry parameters (which our subjects were found to undergo). In elderly subjects, parameters of arterial stiffness derived from applanation tonometry behave much like the previously described carotid-femoral pulse wave velocity. Kingwell, in a review of literature on physical exercise, parameters of arterial stiffness and age found that "aerobic exercise carried out at a moderate level of intensity, but not resistance training performed at high intensity, decreases arterial stiffness in younger subject, whilst elderly patients with isolated systolic hypertension did not show this change" [56] . As one might expect when reading such sweeping and generalised statements, there are examples of studies which do not entirely correlate with these findings. Croymans et al. [57] for example found that resistance training carried out 2 times per week for 12 weeks decreased values of central blood pressure. It should be noted that this study was carried out on young subjects (average age of 21 years of age) who happened to be obese (average BMI of 31 km/m2). It is important to highlight that the study by Croymans et al. noted a correlation between a reduction in central blood pressure and a decrease in oxidized LDL and e-selectin. Our attempt to clarify which factors influenced central blood pressure carried out using regression analysis did not confirm the presence of a significant change in central blood pressure, peripheral blood pressure, reduction in body mass or change in endothelial function. A study by Taaffe et al. [58] found that elderly subjects (aged 65 to 78) who undertook resistance training were noted to experience a decrease in their central systolic pressure. According to the previously cited review of literature by Kingwell, this type of training carried out on this this type of patients should not have had any desirable effects. Body mass index in the study group reduced from 25.62 ± 2.73 to 25.39 ± 2.39 kg/m ² (p=0.001) on visit 2. In four respondents we reported reduction in baseline body weight by 4 kg, in a further seven 3 kg. None of the respondents didn't use an additional program of diet, which further requires the observed reduction in BMI associated with training. The observed changes in BMI was significant, but had no effect on reducing indicators of arterial stiffness in the regression analysis. A similar effect on BMI watched Morales et al. in a group of elderly patients (mean age 69.3 years) with hypertension when used training program which included two 60-minute sessions per week for 12 weeks [59] . It seems that having a longer period of intervention and increased training load in our survey we should expect a greater reduction in BMI. Probably the reduction in adipose tissue mass conducted by implemented training in the younger age group led to an increase in muscle mass, which partially reversed the decline in the BMI.
Our study showed that interval training also appears to beneficially decrease parameters of central hemodynamics such as central pulse pressure and pulse augmentation index, although these effects were not noted in the studies cited above. It seems that the key to success is the application of interval training to hypertensive subjects of an appropriate age group. It should not be applied to subjects that are too young and therefore without arterial remodeling (stiffness), because it is difficult to expect any improvement. Conversely, it should not be applied to subjects that are too elderly as there is no possibility for regression of the permanent and irreversible changes in the arteries. This issue clearly demands further study. Perhaps in the future it will be possible to link physical exercise and its beneficial effects with a decrease in the unfavorable indicators of central hemodynamics obtained from applanation tonometry along with the long term prognosis of patients with hypertension.
Conclusion
Over a period of 5 months, we found that planned aerobic interval training was found to significantly reduce blood pressure, indicators of arterial stiffness, and central pressure in subjects with primary hypertension which was already well controlled using pharmacological methods.
